Authors: Haas, DW Fessel, WJ Delapenha, RA Kessler, H Seekins, D Kaplan, M Ruiz, NM Ploughman, LM Labriola, DF Manion, DJ

Citation: Dw. Haas et al., Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: A randomized, double-blind, placebo-controlled trial, J INFEC DIS, 183(3), 2001, pp. 392-400

Authors: Fessel, WJ Follansbee, SE Young, TP

Citation: Wj. Fessel et al., Salvage therapy and formulation of highly active antiretroviral therapy, J ACQ IMM D, 24(2), 2000, pp. 194-195

Authors: Fessel, WJ Krowka, JF Sheppard, HW Gesner, M Tongson, S Weinstein, S Ascher, M Kwok, S Christopherson, C

Citation: Wj. Fessel et al., Dissociation of immunologic and virologic responses to highly active antiretroviral therapy, J ACQ IMM D, 23(4), 2000, pp. 314-320

Authors: Kaplan, G Thomas, S Fierer, DS Mulligan, K Haslett, PAJ Fessel, WJ Smith, LG Kook, KA Stirling, D Schambelan, M

Citation: G. Kaplan et al., Thalidomide for the treatment of AIDS-associated wasting, AIDS RES H, 16(14), 2000, pp. 1345-1355

Authors: Saag, MS Cloud, GA Graybill, JR Sobel, JD Tuazon, CU Johnson, PC Fessel, WJ Moskovitz, BL Wiesinger, B Cosmatos, D Riser, L Thomas, C Hafner, R Dismukes, WE

Citation: Ms. Saag et al., A comparison of itraconazole versus fluconazole as maintenance therapy forAIDS-associated cryptococcal meningitis, CLIN INF D, 28(2), 1999, pp. 291-296

Authors: Saag, MS Fessel, WJ Kaufman, CA Merrill, KW Ward, DJ Moskovitz, BL Thomas, C Oleka, N Guarnieri, JA Lee, J Brenner-Gati, L Klausner, M

Citation: Ms. Saag et al., Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients, AIDS RES H, 15(16), 1999, pp. 1413-1417